OncoViews
A virtual platform for healthcare professionals to exchange and share knowledge in oncology worldwide.
Next OncoViews on SABCS
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Join our interactive live webinars with leading experts discussing and sharing their views on optimal treatment procedures after SABCS 2020.
OncoViews on ESMO 2020 – Agenda & Speakers
OncoViews on Lung Cancer
23 September 2020
Alfredo Addeo, MD
University Hospital Geneva
Switzerland
Alessandra Curioni, MD
University Hospital Zurich
Switzerland
Christine M. Lovly, MD-PhD
Vanderbilt University Medical Center
Nashville, Tennessee, USA
5:00 pm
(Central European Summer Time)
Leaders in thoracic oncology discuss share their views on latest data in non-small cell and small cell lung cancer.
Non-Oncogene Addicted NSCLC
Alfredo Addeo, MD
SCLC & Mesothelioma
Alessandra Curioni, MD
Oncogene Addicted NSCLC
Christine M. Lovly, MD-PhD
OncoViews on Gastrointestinal Cancers
30 September 2020
Antonia Digklia, MD
University Hospital Lausanne
Switzerland
Richard S. Finn, MD
Jonsson Compr. Cancer Center, UCLA
Los Angeles, California, USA
Thibaud Kössler, MD-PhD
University Hospital Geneva
Switzerland
5:00 pm
(Central European Summer Time)
Join our panel of experts discussing recent discoveries & advances for the treatment of hepatocellular carcinoma as well as gastric and colorectal cancers.
Colorectal Cancer
Antonia Digklia, MD
Hepatocellular Carcinoma
Richard S. Finn, MD
Upper GI & Gastric
Thibaud Kössler, MD-PhD
OncoViews on Genitourinary Cancers
on 7 October 2020
Alex Friedlaender, MD
University Hospital Geneva
Switzerland
Dominik Berthold, MD
University Hospital Lausanne
Switzerland
Elizabeth Plimack, MD
Fox Chase Cancer Center
Philadelphia, Pennsylvania, USA
5:00 pm
(Central European Summer Time)
Leading doctors for genitourinary cancers discuss latest developments for the treatment of prostate and urothelial cancer as well as renal cell carcinoma.
Prostate Cancer
Alex Friedlaender, MD
Renal Cell Carcinoma
Dominik Berthold, MD
Urothelial Carcinoma
Elizabeth Plimack, MD
OncoViews on Melanoma
14 October 2020
Caroline Robert, MD-PhD
Gustave Roussy Cancer Center
Villejuif-Paris, France
Joanna Mangana, MD
University Hospital Zurich
Switzerland
Olivier Michielin, MD-PhD
Switzerland
5:00 pm
(Central European Summer Time)
Take part in the interactive round-table discussion on melanoma with our panel of leading experts.
Metastatic Melanoma
Caroline Robert, MD-PhD
Adjuvant Melanoma
Johanna Mangana, MD
Novel Agents & Biomarkers
Olivier Michielin, MD-PhD
OncoViews on Head & Neck Cancers
on 21 October 2020
Joshua Bauml, MD-PhD
University Hospital Pennsylvania
Philadelphia, Pennsylvania, USA
Jean-Pascal Machiels, MD-PhD
Cliniques Universitaires Saint-Luc, UCLouvain
Brussels, Belgium
Tamara Rordorf, MD
University Hospital Zurich
Switzerland
5:00 pm
(Central European Summer Time)
Don’t miss the discussion with our panel of experts on latest discoveries & advances for the treatment of head & neck cancers.
Current Standard of Care in R/M HNSCC
Jean-Pascal Machiels
Updates in Locally Advanced Head & Neck Cancer
Tamara Rordorf, MD
Future perspectives for the treatment of HNSCC
Joshua Bauml, MD-PhD
Our Partners
This series of OncoViews on ESMO is kindly supported by our partners with no influence on the content:
OncoViews on Lung Cancer – ADAURA: The Debate
Did you miss our LIVE DEBATE?
No worries! The discussion is recorded and available now on demand.
The lung cancer community has been discussing for weeks – now it is time for the debate! In collaboration with the International Lung Cancer Summit and Key Opinion Leaders in the field of lung cancer, we proudly present OncoViews on ADAURA – The Debate!
Sign up below and don’t miss any of our future initiatives.
Joshua Bauml, MD-PhD
University Hospital Pennsylvania, USA
Solange Peters, MD-PhD
University Hospital Lausanne, Switzerland
Howard (Jack) West, MD
City of Hope, Comprehensive Cancer Center, USA
Watch Our Virtual Round-Tables Following ASCO2020
Our discussions on Gastrointestinal, Lung, Genitourinary and Women’s Cancers from ASCO 2020 are recorded and available for you behind the login curtain.
OncoViews on GI Cancers
from 10 June 2020
Mike Pishvaian, MD-PhD
Washington DC, USA
Thibaud Kössler, MD-PhD
Switzerland
Nina Sanford, MD
Dallas, Texas, USA
Alexander Siebenhüner, MD
Switzerland
OncoViews on Lung Cancer
from 17 June 2020
Maximilian Hochmair, MD
Austria
Solange Peters, MD-PhD
Switzerland
Martin Reck, MD-PhD
Germany
OncoViews on GU Cancers
from 24 June 2020
Alex Friedlaender, MD
Switzerland
Aurelius Omlin, MD
Switzerland
Cora Sternberg, MD
New York, USA
OncoViews on Women’s Cancers
from 01 July 2020
Konstantin Dedes, MD
Switzerland
Matteo Lambertini, MD-PhD
Italy
Apostolos Sarivalasis, MD
Switzerland
FAQs
Will I be able to re-access the videos?
Yes, absolutely. The content is recorded and made available within 24 hours on our portal so that you can play it on demand as often as you like.
Does it cost me anything?
Access to the debates are completely free! Access to our round-table portal is free of charge for healthcare professionals, students, scientists or other staff from universities, hospitals & research labs as well as policy & non-profit organisations and sponsoring partners. Only registrations by non-sponsoring industry representatives are subject to a fee.
Why do you need my details for registration?
In accordance with Swiss and European regulations, we require some information about you for verification purposes to ensure that the content of our initiatives is aimed at healthcare professionals and those involved in the science, management and treatment of cancer. We will not share your personal details with any sponsor or any third party - promised!
How can I get involved in the discussion?
During the live webinar, you may submit your questions to our panel of experts and with that interact and influence the discussion.
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Watch Our Virtual Round-Tables on Latest in Oncology
The virtual round-table and online content is only accessible to students of medicine and life sciences, certified healthcare professionals, associated press, industry representatives and other stakeholders in the science, management and prevention of cancer.